Intelligence Unit Special Reports Special Events Subscribe Sponsored Departments Follow Us

Twitter Facebook LinkedIn RSS

FDA greenlights first drug-eluting stent in more than three years, February 19, 2008
The Food and Drug Administration has approved Medtronic's Endeavor zotarolimus-eluting coronary stent system to be used in the treatment of coronary artery disease. It is the first new drug-eluting stent to be approved by the FDA since 2004.